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As neuronal development progresses, GABAergic synaptic transmission undergoes a deﬁned program of
reconﬁguration. For example, GABAA receptor (GABAAR)-mediated synaptic currents, (miniature inhibi-
tory postsynaptic currents; mIPSCs), which initially exhibit a relatively slow decay phase, become pro-
gressively reduced in duration, thereby supporting the temporal resolution required for mature network
activity. Here we report that during postnatal development of cortical layer 2/3 pyramidal neurons,
GABAAR-mediated phasic inhibition is inﬂuenced by a resident neurosteroid tone, which wanes in the
second postnatal week, resulting in the brief phasic events characteristic of mature neuronal signalling.
Treatment of cortical slices with the immediate precursor of 5a-pregnan-3a-ol-20-one (5a3a), the
GABAAR-inactive 5a-dihydroprogesterone, (5a-DHP), greatly prolonged the mIPSCs of P20 pyramidal
neurons, demonstrating these more mature neurons retain the capacity to synthesize GABAAR-active
neurosteroids, but now lack the endogenous steroid substrate. Previously, such developmental plasticity
of phasic inhibition was ascribed to the expression of synaptic GABAARs incorporating the a1 subunit.
However, the duration of mIPSCs recorded from L2/3 cortical neurons derived from a1 subunit deleted
mice, were similarly under the developmental inﬂuence of a neurosteroid tone. In addition to principal
cells, synaptic GABAARs of L2/3 interneurons were modulated by native neurosteroids in a development-
dependent manner. In summary, local neurosteroids inﬂuence synaptic transmission during a crucial
period of cortical neurodevelopment, ﬁndings which may be of importance for establishing normal
network connectivity.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The postnatal brain undergoes considerable neuronal plasticity
to meet the changing demands of rapidly developing networks.
During this critical time the duration of synaptic events mediated
by GABAARs becomes progressively reduced, permitting post-
synaptic neurons to respond to input from certain fast-spiking
GABA-ergic interneurons and thereby appropriately inﬂuence the
temporal window for postsynaptic excitation (Whittington et al.
2011; Deidda et al. 2014; Fritschy and Panzanelli, 2014)., Medical Research Institute,
sity, Dundee, DD1 9SY, UK.
bert).
a Park, Cambridge, UK.
r Ltd. This is an open access articleAlterations to the subunit composition of synaptic GABAARs are
implicated in producing these crucial changes to inhibitory post-
synaptic current (IPSC) kinetics (Brickley et al. 1996; Okada et al.
2000; Vicini et al. 2001; Juttner et al. 2001; Goldstein et al. 2002;
Bosman et al. 2005; Takahashi, 2005; Fritschy and Panzanelli,
2014; Deidda et al. 2014). GABAARs are members of the Cys-loop
transmitter-gated ion channel family and in common with
glycine, nicotinic acetylcholine and 5HT3 receptors are composed of
ﬁve subunits (Olsen and Sieghart, 2008). In mammals 19 subunit
genes underpin the expression of ~20e30 native GABAAR subtypes,
which display distinct pharmacological and physiological proper-
ties (Olsen and Sieghart, 2008). In the CNS, these GABAAR subtypes
exhibit a heterogeneous expression pattern, which importantly in
many neurons is known to change during neonatal development
(Olsen and Sieghart, 2008; Fritschy and Panzanelli, 2014; Rudolph
and Mohler 2014). In particular, an increased expression ofunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Abbreviations
a1/ GABAAR a1 subunit “knockout”.
5a3a 5a-pregnan-3a-ol-20-one; allopregnanolone.
5a-DHP 5a-dihydroprogesterone, or 5a-pregnane-3,20-dione.
5a-R 5a-reductase.
CD cyclodextrin
tw weighted decay time constant of mIPSC decay.
aCSF artiﬁcial cerebrospinal ﬂuid.
ANOVA analysis of variance statistical test.
DMSO dimethylsulphoxide.
ECS extracellular solution.
GABA g-aminobutyric acid.
GABAAR g-aminobutyric acid type A receptor.
GAD67-GFP glutamic acid decarboxylase-green ﬂuorescent
protein.
ICS intracellular solution.
KS KolmogoroveSmirnov statistical test.
L2/3 cortical layer 2/3.
mIPSC miniature inhibitory postsynaptic current.
P postnatal day.
S.E.M standard error of the mean.
T50 time taken for mIPSCs to decay from peak amplitude
by 50%.
TTX tetrodotoxin.
VB ventrobasal.
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in the appearance of short duration IPSCs (Okada et al. 2000; Vicini
et al. 2001; Peden et al. 2008; Eyre et al. 2012; Deidda et al. 2014;
Fritschy and Panzanelli, 2014). However, during development of
thalamocortical inhibitory synapses, changes to IPSC kinetics occur
prior to the temporal expression of the a1 subunit (Peden et al.
2008; Brown et al. 2015), implicating, at least in these neurons,
additional factor(s) that inﬂuence GABAAR ion channel gating
properties.
Certain naturally occurring neurosteroids act in a non-genomic
manner as endogenous positive allosteric modulators of the
GABAAR (Belelli and Lambert, 2005; Zorumski et al. 2013). The
cortical levels of these neurosteroids change during neonatal
development (Grobin and Morrow, 2001). Furthermore, the en-
zymes required to synthesize these GABAAR-active steroids are
expressed in certain neurons, suggesting that these local neuro-
modulators may act as paracrine, or autocrine messengers, to
locally inﬂuence neuronal inhibition (Agis-Balboa et al., 2006; Do
Rego et al., 2009; Castelli et al. 2013; Brown et al. 2015). Here, we
demonstrate for mouse cortical L2/3 pyramidal neurons and in-
terneurons that during early (P7-15) neonatal development, their
synaptic GABAARs are inﬂuenced by an endogenous neurosteroid
tone, which consequently prolongs the duration of phasic
GABAergic neurotransmission. During subsequent development
this modulation wanes, such that by P20-24 it has dissipated,
resulting in brief IPSCs, characteristic of mature inhibitory synap-
ses. However, when provided with 5a-dihydroprogesterone (5a-
DHP), the 5a3a precursor, these more mature neurons retain the
capacity to synthesise GABAAR-active neurosteroids, suggesting
that the developmental changes to GABAergic neurotransmission
reﬂect a timed loss of steroid substrate, acting in concert with the
established ontogenetic pattern of a1 subunit expression. Impor-
tantly, neurosteroid levels are not static, but are perturbed in a
variety of physiological and pathophysiological conditions (Belelli
and Lambert, 2005; Zorumski et al. 2013). Therefore, given the
role GABAARs may play in a number of disorders including autism,
schizophrenia, Fragile X and Down syndrome (Deidda et al., 2014;
Rudolph and Mohler, 2014), these ﬁndings may not only be
important in better understanding how phasic GABAergic neuro-
transmission changes to accommodate the demands of neuronal
network activity during development, but may additionally allow
new insights into the pathology of certain neurodevelopmental
disorders.
2. Materials & methods
2.1. Breeding of mice
All animal studies were approved by the University of DundeeEthical Review Committee (Home Ofﬁce Project Licenses 60/4005
and 70/8161, Dr. Belelli), and complied with Schedule 1 of the UK
Government Animals (Scientiﬁc Procedures) Act, 1986. Transgenic
a1 subunit ‘knockout’ (a1/) mice were generated on a mixed
C57BL6-129SvEv background (Sur et al. 2001). Transgenic GAD 67-
GFP “knock-in” mice were generated on a C57BL/6J background as
described previously (Tamamaki et al. 2003). Electrophysiological
experiments were performed on brain slices prepared from the ﬁrst
2e3 generations of a1/, GAD67-GFP, or corresponding WT
offspring from heterozygous (þ/) breeding pairs housed at the
University of Dundee.
2.2. Preparation of brain slices for electrophysiology
Cortical slices were prepared from postnatal day (P) P7 - 24WT,
a1/, or GAD 67-GFP mice of either sex. Mice were killed by cer-
vical dislocation, the brain dissected and placed in ice-cold
oxygenated (95% O2/5%CO2) artiﬁcial cerebrospinal ﬂuid (aCSF)
containing (in mM): 225 sucrose, 2.95 KCl, 1.25 NaH2PO4, 26
NaHCO3, 0.5 CaCl2, 10 MgSO4, 10 glucose, (pH 7.4; 328e330 mOsm).
The brain was sectioned in the coronal plane using a Vibratome
series 1000 PLUS Sectioning System (Intracell, Royston, Hertford-
shire, UK). Slices were cut at 300e350 mm thickness for mice of P15,
or older, and 400 mm, for younger animals. Slices were immediately
transferred on to a nylon mesh platform housed within a chamber
containing circulating oxygenated extracellular solution (ECS, in
mM: 126 NaCl, 26 NaHCO3, 2.95 KCl,1.25 NaH2PO4, 2MgCl2, 2 CaCl2,
10 glucose [306e309 mOsm]) and allowed to rest at room tem-
perature for a minimum of 1 h before electrophysiological
recording.
2.3. Voltage-clamp recording
During recording, cortical slices were perfused with ECS main-
tained at 35 C using a gravity based perfusion system set to a ﬂow
rate of 3e5 ml/min and recycled to a 50 ml oxygenated reservoir
using a peristaltic pump (Minipuls 3, Gilson, UK). Intracellular so-
lution (ICS) containing (in mM): 135 CsCl, 10 HEPES, 10 EGTA, 2
MgCl2, 1 CaCl2, 2 Mg-ATP and 5 QX-314 (pH 7.2e7.3,
290e300 mOsm) was used for whole-cell recording. Patch pipettes
were pulled from thick-walled borosilicate glass (0.95 mm I.D.
1.55 mm E.D. Garner Glass Co. Claremont, CA), using a Narashige
PC-10 electrode puller (Narashige, Japan). When ﬁlled with the
above ICS, pipettes with an open tip resistance of 2e6 MU were
obtained. Neurons were visually identiﬁed for investigation using
an upright Olympus BX50WI microscope (Olympus, Southall, UK)
equipped with IR-DIC optics. Pyramidal neurons located within
cortical L2/3 were identiﬁed based on their canonical pyramidal
morphology. L2/3 GABAergic interneurons were identiﬁed in
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epiﬂuorescence microscopy. Neurons were voltage-clamped
at 60 mV using an Axopatch 1D ampliﬁer (Molecular Devices,
CA, USA) and ﬁltered at 2 kHz. GABAAR-mediated mIPSCs were
isolated by supplementing the ECS with kynurenic acid (2 mM),
tetrodotoxin (TTX, 500 nM) and strychnine (1 mM). Data was ac-
quired and digitised (10 kHz) using a NIDAQ mx card (National
Instruments, TX, USA) and stored directly to PC using WinEDR
software (Strathclyde University, UK). Series resistance compen-
sation was applied up to 80%. Recordings were omitted from
analysis if the series resistance changed by more than 20% during
the experiment, or if they exceeded 15 MU.
2.4. Drugs and reagents
For in vitro experiments, ﬁnasteride, indomethacin, 5a3a and
5a-DHPwere prepared as concentrated stock solutions (1000x ﬁnal
concentration) in DMSO, whereas bicuculline methobromide and
TTX were prepared as concentrated stock solutions in distilled
water. Drug stock solutions were diluted to the ﬁnal required
concentration in ECS, whereas kynurenic acid was dissolved
directly into the ECS. Similarly, a-CD and g-CD were dissolved
directly into the extracellular and intracellular solution.
For acute studies with 5a3a (1 mM), the steroid was perfused
directly in to the recording chamber, with the effect determined on
mIPSCs acquired after ~ 7 min of drug contact with the slice
preparation. To investigate the impact of prolonged exposure to
either 5a3a (100 nM), or 5a-DHP (3 mM), the test steroid was pre-
incubated with the cortical slice at room temperature for > 2 h,
before the tissue was transferred to the recording chamber, where
it was continuously perfused with ECS (see Section 2.3 above)
containing the test steroid. Note for some experiments with 5a-
DHP (3 mM) the cortical slice was co-incubated with indomethacin
(100 mM). The CD studies employed two protocols: the ﬁrst
involved pre-incubating cortical slices in the holding chamber at
room temperature with either a-, or g-CD (1 mM, >1 h). Recordings
were then made with both ECS and ICS containing the CD (1 and
0.5 mM, respectively). In the second protocol, CD was included only
in the recording pipette (0.5 mM). When the CD was applied to the
intracellular compartment alone, mIPSCs were only included for
analysis if they were recorded for at least 6 min after obtaining
whole-cell access. To examine the inﬂuence of inhibiting the 5a-R
enzyme, ﬁnasteride (50 mM) was pre-incubated with the cortical
slice in a holding chamber containing oxygenated ECS (at room
temperature) for > than 4 h prior to recording. Subsequent re-
cordings from such slices were made either with a control intra-
cellular pipette solution, or with the pipette containing g-CD, to
determine the combined inﬂuence of intracellular g-CD and ﬁ-
nasteride treatment. Note the ﬁnal DMSO concentration (0.1%) had
no effect on any of the mIPSC parameters measured.
2.5. Electrophysiological analysis
Digitized data was analysed ofﬂine using WinEDR/WinWCP
software (Strathclyde University, UK). The mIPSCs were identiﬁed
by an algorithmic detection protocol. To eliminate distal events,
which may be affected by imperfect voltage-clamp, Gaussian dis-
tributions of 10e90% rise time were generated and mIPSCs falling
outside the Gaussian limits were excluded. Individual mIPSCs were
visually inspected and spurious events omitted. Typically, for each
neuron data from 50, or more mIPSCs were analysed with respect
to their peak amplitude, 10e90% rise time, and time taken to decay
from peak by 50% (T50). Accepted mIPSCs recorded from a single
neuron were averaged and ﬁtted with either a mono-exponential
(y(t) ¼ Ae(t/t)), or bi-exponential (y(t) ¼ A1e(t/t1) þ A2e(t/t2))decay function, where y(t) is the current amplitude at time t, A is
the current amplitude and t is the decay time constant. To compare
goodness of ﬁt between a mono- or bi-exponential decay, an F test
was applied to the standard deviation of the residuals. The over-
whelming majority of mIPSC decay times analysed were best ﬁt by
a bi-exponential function. Subsequently, a mean weighted decay
constant (tw) was calculated to accommodate the relative contri-
bution of each decay component whereby:
tw ¼ t1P1þt2P2
Here, t1 and t2 are the decay time constants for the ﬁrst and
second exponential functions, and P1 and P2 are the proportions of
current amplitude described by each component i.e.
P1 ¼ A1
A1þ A2 P2 ¼
A2
A1þ A2
All reported data are expressed as mean values ± standard error
of the mean (S.E.M.). To determine statistical signiﬁcance, Student's
t-tests (paired, or unpaired) and ANOVA (one or two-way, followed
post-hoc by Tukey's HSD or independent samples t-test, SigmaStat,
Systat Software Inc. San Jose, CA, USA) were used as appropriate.
For comparison of cumulative probability distributions of mIPSC
T50 values, the Kolmogorov-Smirnoff (KS) test was used (SPSS
software, Chicago, IL, USA).3. Results
3.1. The inﬂuence of development on phasic currents, mediated by
synaptic GABAARs of L2/3 cortical pyramidal neurons
The properties of mIPSCs (frequency, amplitude and kinetics),
recorded from WT L2/3 pyramidal neurons, obtained from
neonatal/juvenile (P7 - 15) to adolescent (P20 - 24) mice, changed
with development (Fig. 1; Table 1). Of particular note, with age the
mIPSC frequency increased considerably (e.g. P7 - 8 ¼ 1.2 ± 0.2 Hz,
n ¼ 55 neurons; P20 - 24 ¼ 11.7 ± 1.2 Hz, n ¼ 25 neurons e Fig. 1;
Table 1). Furthermore, the mIPSC decay time, as quantiﬁed by
determination of theweighted decay time constant (tW), decreased
with development. Speciﬁcally, P7 - 8 neurons exhibited mIPSCs
with a relatively prolonged decay (tW¼ 12.1 ± 0.3 ms; n¼ 55), that
by P15 had become signiﬁcantly reduced (tW ¼ 6.5 ± 0.3 ms;
n ¼ 14; one way ANOVA; p < 0.001 vs P7 - 8, Fig. 1C, Table 1). With
the proﬁle of mIPSC decay kinetics between P7 - 8 and P20 - 24
established, investigations now focused on whether the mIPSCs of
L2/3 pyramidal neurons are inﬂuenced by endogenous
neurosteroids.3.2. Phasic GABAergic transmission from P7 - 8 cortical L2/3
pyramidal neurons is inﬂuenced by an endogenous neurosteroid
tone
To test for endogenous modulation of GABAergic neurotrans-
mission by neurosteroids, we utilized g-CD, a neurosteroid scav-
enger (Shu et al. 2007; Brown et al. 2015). For P7 - 8 neurons, the g-
CD pre-incubation protocol (>1 h. see Methods) had no effect on
the mIPSC frequency, or amplitude (in both cases p > 0.05, one way
ANOVA), but greatly reduced their duration (tW
control ¼ 12.1 ± 0.3 ms, n ¼ 55, vs tW g-CD ¼ 8.5 ± 0.2 ms, n ¼ 20,
p < 0.001, one way ANOVA, Fig. 2A, F, G Table 1). The structurally
related a-CD is ineffective in sequestering pregnane steroids, as the
pore diameter of the molecule is smaller (6 vs 8 cyclic sugars) than
that of g-CD (Davis and Brewster, 2004; Shu et al. 2004, 2007;
Brown et al. 2015). Importantly, the equivalent treatment with a-
Fig. 1. The properties of mIPSCs recorded fromWT L2/3 pyramidal neurons during
postnatal development. A). Traces showing typical current recordings from L2/3 py-
ramidal neurons derived from WT mice at P7 (top), P10 (middle) and P20 (bottom).
Note the increase in the frequency of synaptic events with development. B). Averaged,
superimposed mIPSCs normalised with respect to peak amplitude, recorded from
representative WT L2/3 pyramidal neurons of P7, P10, P15 and P20 mice. The decay
time decreases progressively with development. C). A graph showing both the net
decrease in tW, and the concomitant increase in mIPSC frequency (n ¼ 14e55 neurons)
occurring with development. Symbols represent the mean ± S.E.M.
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way ANOVA, Fig. 2B, F, G).
To conﬁrm that the reduced decay times observed following g-
CD were due to neurosteroid sequestration, we pre-incubated P7 -
8 WT cortical brain slices with the 5a-reductase inhibitor ﬁnaste-
ride (50 mM > 4 h), which signiﬁcantly reduced the mIPSC duration
(tW control ¼ 12.1 ± 0.3 ms, n ¼ 55; tW ﬁnasteride ¼ 8.5 ± 0.3 ms,
n¼ 7, p < 0.001, oneway ANOVA, Fig. 2C, F, G, Table 1). This effect on
themIPSC durationwas indistinguishable from that produced by g-
CD (ﬁnasteride tW ¼ 8.5 ± 0.3 ms, n ¼ 7, g-CD tW ¼ 8.5 ± 0.2 ms,
n ¼ 20; p > 0.05, one way ANOVA, Fig. 2F, G, Table 1). Collectively,
these ﬁndings indicate that an endogenous neurosteroid tone in-
ﬂuences synaptic GABAARs at P7 e 8.
Interpretation of the combined effects of ﬁnasteride and g-CD is
potentially complicated, as given that ﬁnasteride is a steroid, it isTable 1
A summary of the impact of development and g-CD, or ﬁnasteride preincubation on t
control, unpaired t-test.yyy ¼ p < 0.001, vs control, one way ANOVA with Tukey post hoc
P7/8 P10
Control
(n ¼ 55)
g-CD
(n ¼ 20)
FIN
(n ¼ 7)
Control
(n ¼ 20)
g-
(n
Peak amplitude (pA) 50 ± 3 48 ± 3 63 ± 3 46 ± 2 
Rise time (ms) 0.6 ± 0.1 0.6 ± 0.1 0.5 ± 0.1 0.6 ± 0.1 0
tW (ms) 12.1 ± 0.3 8.5 ± 0.2yyy 8.5 ± 0.3yyy 10.5 ± 0.5 7
Frequency (Hz) 1.2 ± 0.2 1.2 ± 0.2 1.8 ± 0.4 2.2 ± 0.3 2conceivable that the extracellular g-CD may sequester this 5a-
reductase inhibitor. We have previously demonstrated that intra-
cellular g-CD alone is equi-effective in inﬂuencing the mIPSCs of
developing thalamic neurons (Brown et al., 2015), suggesting a
protocol to avoid this complexity. Therefore, we ﬁrst investigated
the effect on cortical mIPSCs of incorporating the membrane-
impermeant g-CD (0.5 mM) solely in the recording pipette (ICS g-
CD). This treatment (recordings made > 6 min after achieving the
whole-cell recording conﬁguration) signiﬁcantly reduced the
mIPSC tW (control ¼ 12.1 ± 0.3 ms, n ¼ 55; g-CD ICS: 9.2 ± 0.6 ms,
n ¼ 6, p < 0.05, one way ANOVA, Fig. 2D, F, G), an effect indistin-
guishable from that of g-CD resulting from the pre-incubation
protocol (g-CD pre-incubation: 8.5 ± 0.2 ms, n ¼ 20, p > 0.05,
one way ANOVA, Fig. 2F, G) and not signiﬁcantly different from that
produced by ﬁnasteride (50 mM) treatment (p > 0.05, one way
ANOVA tW ¼ 8.5 ± 0.3 ms, n ¼ 7, Fig. 2F, G). Finally, we now
determined the combined effect of ﬁnasteride and g-CD treatment.
For P7 - 8 neurons, treatment of the slice with ﬁnasteride (50 mM)
for > 4 h, followed by intracellular g-CD (0.5 mM), resulted in
mIPSCs with a signiﬁcantly reduced duration (tw ¼ 7.3 ± 0.2 ms;
n ¼ 6, p < 0.001, one way ANOVA), that was not signiﬁcantly
different from that produced solely by ﬁnasteride, or by intracel-
lular g-CD alone (p > 0.05, one way ANOVA, Fig. 2E, F, G).
3.3. The neurosteroid inﬂuence on phasiceGABAergic transmission
of cortical L2/3 pyramidal neurons changes during development
We next assessed whether neurosteroids contribute to the
developmental changes in the duration of phasic GABAergic events
by determining the effect of g-CD on the mIPSCs of neurons at
different stages of development (Brown et al. 2015). Treatment
with g-CD reduced the decay time of mIPSCs recorded from P7 - 8,
P10 and P15 neurons, relative to their respective controls (Fig. 3,
Table 1). However, the developmental stage signiﬁcantly inﬂuenced
the effect of g-CD on the mIPSC decay time (Fig. 3, age  treatment
interaction, F3,157 ¼ 6.15, p < 0.001, two-way ANOVA), such that by
P20-24, g-CD had no signiﬁcant effect (control tw ¼ 5.4 ± 0.2 ms
n¼ 25; g-CD¼ 5.3 ± 0.6 ms; n¼ 8; p > 0.05; independent samples
t-test, Fig. 3). Further implicating a changing neurosteroid impact
during development, the effect of ﬁnasteride (50 mM) was also
signiﬁcantly inﬂuenced by post-natal age (Fig. 3, age  treatment
interaction, F2,127 ¼ 10.47, p < 0.001, two-way ANOVA), such that, in
contrast to P7 e P8 recordings, ﬁnasteride had no signiﬁcant effect
on the mIPSC duration of P20 e P24 neurons (control
tW ¼ 5.4 ± 0.2 ms; n ¼ 25; ﬁnasteride tW ¼ 5.3 ± 0.2 ms; n ¼ 6;
p > 0.05, post-hoc Tukey HSD, Fig. 3).
3.4. Decreased neurosteroid synthesis contributes to the changes to
phasic GABAergic transmission evident in P20-24 cortex
The loss of neurosteroid inﬂuence on phasic inhibition of P20 -
24 pyramidal neurons, inferred by both the ﬁnasteride and g-CD
experiments, may be due to the synaptic GABAARs becoming
neurosteroid-insensitive (Koksma et al. 2003), or alternatively ahemIPSC properties of WT L2/3 pyramidal neurons.* ¼ p < 0.05,*** ¼ p < 0.001, vs
test.
P15 P20-24
CD
¼ 11)
Control
(n ¼ 14)
g-CD
(n ¼ 12)
Control
(n ¼ 25)
g-CD
(n ¼ 8)
FIN
(n ¼ 6)
47 ± 4 54 ± 3 45 ± 1* 42 ± 2 42 ± 3 50 ± 5
.6 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1
.3 ± 0.4*** 6.5 ± 0.3 5.2 ± 0.3* 5.4 ± 0.2 5.3 ± 0.6 5.3 ± 0.2
.6 ± 0.5 12.9 ± 2.0 12.4 ± 2.8 11.7 ± 1.2 12.6 ± 3.3 9.1 ± 0.7
Fig. 2. GABAergic synaptic currents of L2/3 pyramidal neurons are inﬂuenced by an endogenous neurosteroid tone during early postnatal development. A - E). Averaged
mIPSCs, superimposed and normalised with respect to peak amplitude from a representative P7 cortical pyramidal neuron during control conditions (black line) and following
treatment (grey lines) with either, A) 1 mM g-CD, B) 1 mM a-CD, C) 50 mM ﬁnasteride (Fin), D) 0.5 mM g-CD in the ICS only, or E) 50 mM ﬁnasteride þ 0.5 mM g-CD in the ICS. F). A
cumulative probability plot of the mIPSC T50 for control P7 - 8 L2/3 pyramidal neurons (events pooled from 55 cells) and P7 - 8 L2/3 pyramidal neurons following treatment
conditions described above. All treatments apart from a-CD resulted in a signiﬁcant leftward shift in the T50 distribution indicating that these treatments resulted in mIPSCs with
reduced decay times compared with control (in all cases p < 0.001, KS-test). G) Summary bar graph depicting the mean tw values for P7 - 8 mIPSCs for control and after cyclodextrin/
ﬁnasteride treatments (n ¼ 6e55 cells). * ¼ p < 0.05, *** ¼ p < 0.001, vs control. n.s. ¼ not signiﬁcant, one way ANOVA with Tukey post hoc test.
Fig. 3. The cortical neurosteroid tone is developmentally regulated. A bar graph
showing the effect of g-CD pre-incubation (1 mM) on the tW of mIPSCs recorded from
WT L2/3 pyramidal neurons during development (n ¼ 8e55 cells). Note that at P7 - 8,
P10 and P15 the g-CD pre-incubation resulted in a signiﬁcant reduction in tW vs
control. For comparison, the effect of ﬁnasteride (50 mM) preincubation at P7 - 8 and
P20 - 24 is also shown (n ¼ 6e55 cells). yyy ¼ p < 0.001, vs control, post hoc Tukey HSD
test following two-way ANOVA. * ¼ p < 0.05, *** ¼ p < 0.001, vs control, post-hoc
independent samples t-test following two-way ANOVA. n.s. ¼ not signiﬁcant. The in-
dependent variables for the two-way ANOVAs were postnatal age and treatment (g-
CD, or ﬁnasteride). Illustrated above each developmental time point are the corre-
sponding averaged and superimposed mIPSCs, normalised with respect to peak
amplitude, obtained from representative pyramidal neurons in the absence (control,
black line) and following 1 mM g-CD pre-incubation (grey line).
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steroid interactionwith GABAARsmay be inﬂuenced by factors such
as subunit composition and phosphorylation status (Koksma et al.
2003; Belelli and Lambert, 2005). We therefore investigated
whether GABAARs expressed by P20 - 24 L2/3 pyramidal neurons
retained neurosteroid sensitivity. The acute bath application of
exogenous 5a3a (1 mM, whereby mIPSCs were analysed before, and
after ~ 7 min application of the steroid) resulted in mIPSCs with a
signiﬁcantly prolonged decay phase (control tW: 5.5 ± 0.5 ms vs
1 mM 5a3a tW: 8.7 ± 1.7 ms, n ¼ 7, p < 0.05, paired t-test). For
isolated single cell studies, acutely applied 5a3a acts at nM aqueous
concentrations to enhance GABAAR function (Pistis et al. 1997;
Belelli and Lambert, 2005). Therefore, the relatively limited effect
of acutely applied 5a3a at the relatively high concentration of 1 mM
might suggest that these cortical synaptic GABAARs are relatively
insensitive to the neurosteroid by P20-24. Alternatively, the effect
of the steroid when applied acutely to a brain slice may be
underestimated. In support of the latter, the general anesthetics
etomidate and propofol, which in common with neurosteroids are
lipophilic and efﬁcacious GABAAR modulators, require several
hours to approach equilibrium within in vitro brain slice prepara-
tions (Gredell et al. 2004; Benkwitz et al. 2007). To ascertain
whether the GABA modulatory effects of 5a3a are underestimated
when applied acutely to a cortical slice, we determined the effect of
a lower concentration (100 nM) of 5a3a on the mIPSCs of P20-24
L2/3 pyramidal neurons, but now pre-incubated (>2 h), before
being continuously applied during the recording. Employing this
protocol, the 10 fold lower concentration of 5a3a (100 nM) pro-
duced a clear and large prolongation of the mIPSC decay (control
tW¼ 5.4 ± 0.2 ms, n¼ 25 vs 5a3a 100 nM tW¼ 12.6 ± 0.9 ms, n¼ 5,
A.R. Brown et al. / Neuropharmacology 103 (2016) 163e173168p < 0.001, one way ANOVA; post-hoc Tukey HSD Fig. 4A, C).
Importantly, this experiment establishes that P20 - 24 cortical
synaptic receptors retain sensitivity to nM aqueous concentrations
of this neurosteroid and consequently, the change in mIPSC decay
at this stage of development is not due to neurosteroid-insensitive
synaptic GABAARs.
To determine whether more mature (P20 - 24) L2/3 cortical
pyramidal neurons retain the capacity to synthesize GABAAR-active
neurosteroids, we investigated the inﬂuence of the GABAAR-inac-
tive steroid 5a-DHP, the immediate precursor of 5a3a (Brown et al.
2015). We had previously shown that a prolonged incubation
(>2 h), but not a short incubation (30e60 min) of thalamic slices
with 5a-DHP prolonged the mIPSC decay phase of VB neurons
(Brown et al. 2015). Here, pre-incubation of the cortical slice with
5a-DHP (3 mM) for > 2 h, followed by continuous perfusion of this
steroid during the recording (see Methods), resulted in greatly
prolonged mIPSCs (control tW ¼ 5.4 ± 0.2 ms, n ¼ 25 vs 5a-DHP
tW¼ 16.1 ± 0.6ms, n¼ 7, p< 0.001, oneway ANOVA - see Fig. 4B, C).
This effect was markedly reduced by co-incubation with the 3a-
HSD inhibitor indomethacin (100 mM; tW¼ 6.3± 0.4ms; n¼ 6; post
hoc Tukey HSD p < 0.001), or by intracellular (0.5 mM) g-CD
(tW¼ 8.7 ± 0.3 ms; n¼ 6, post hoc Tukey HSD p < 0.001) - Fig. 4B, C.
Therefore, when provided with the immediate precursor, cortical
tissue from P20-24 mice retains the ability to synthesize GABAAR-
active neurosteroids. Furthermore, these data provide additional
evidence that their synaptic GABAARs remain neurosteroid
sensitive.Fig. 4. The synaptic GABAARs of P20 e 24 L2/3 cortical pyramidal neurons are neurostero
active neurosteroids. A). Averaged, superimposed mIPSCs normalised with respect to peak a
slices derived from P20 - 24 mice, under control conditions and following incubation (>120
respect to peak amplitude, recorded under control conditions and following incubation (>12
5a-DHP (>120 min); or incubation with 3 mM 5a-DHP (>120 min) followed by 0.5 mM ICS
incubation of 100 nM 5a3a; 5a-DHP incubation and the much reduced 5a-DHP effect follow
to the ICS (n ¼ 5e25 cells). *** ¼ p < 0.001 vs control, one way ANOVA with Tukey post ho3.5. Phasic GABAergic transmission of L2/3 pyramidal neurons is
inﬂuenced both by an endogenous neurosteroid tone and by the
subunit composition of synaptic GABAARs
Despite treatment with g-CD, the mIPSC decay time still
decreased with development, with a similar trend observed for
ﬁnasteride-treated neurons (Fig. 3, Table 1). These observations
suggest that factors additional to neurosteroids inﬂuence phasic
inhibition during development. Numerous studies have implicated
changes to the subunit composition of synaptic GABAARs to be
important in this respect, with a particular emphasis on the role of
the a1 subunit (Rovira and Ben-Ari, 1993; Tia et al. 1996; Hollrigel
and Soltesz, 1997; Dunning et al. 1999; Kapur andMacdonald,1999;
Vicini et al., 1999, 2001; Okada et al. 2000; Ortinski et al. 2004). To
investigate whether a1-GABAARs inﬂuence mIPSCs during the
development (P7 e 24) of L2/3 pyramidal neurons, cortical brain
slices were prepared from mice engineered to lack the a1 subunit
(a1/). The decay phase of a1/ mIPSCs was prolonged in com-
parison to their WT counterparts, but, importantly, this occurred at
all ages examined here (two-way ANOVA, age  genotype inter-
action, F3,139 ¼ 5.75, p ¼ 0.001; for post-hoc WT vs a1/ compar-
isons, p < 0.001 for P7 - 8, P10, P15 and P20, Fig. 5). However, in
common with WT neurons, the a1/ mIPSC decay phase became
faster with development (p < 0.001, one way ANOVA, Fig. 5;
Table 2), suggesting that factors other than increased expression of
a1-subunit containing GABAARs must contribute to the develop-
mental proﬁle. In agreement, and further implicating a role forid sensitive and furthermore, P20 e 24 cortical brain slices can synthesise GABAAR-
mplitude, recorded from representativeWT L2/3 cortical pyramidal neurons from brain
min) with 100 nM 5a3a. B) Averaged, superimposed P20-24 mIPSCs normalised with
0 min) with 3 mM 5a-DHP; co-incubation with 100 mM indomethacin (Indo) and 3 mM
g-CD. C) Summary bar graph illustrating the increase in the mIPSC tw in response to
ing either co-incubation with 100 mM indomethacin (Indo), or addition of 0.5 mM g-CD
c analysis.
Fig. 5. The effect of a1 subunit deletion on the tW of mIPSCs recorded from L2/3
neurons during development. A bar graph comparing tW of mIPSCs recorded from
WT and a1/ L2/3 neurons during postnatal development (n ¼ 4e13 a1/ neurons).
The WT data is adapted from Fig. 1. Note that the decay time of mIPSCs of both WT and
a1/ L2/3 pyramidal neurons, becomes reduced with age. However, at each devel-
opmental stage, mIPSCs recorded from a1/ neurons exhibit a slower decay c.f. those
recorded from equivalent WT neurons (*** ¼ p < 0.001, post-hoc independent samples
t-test following two-way ANOVA, with postnatal age and genotype as the independent
variables). Illustrated above each developmental time point are corresponding aver-
aged and superimposed mIPSCs, normalised with respect to peak amplitude, obtained
from representative WT (black line) and a1/ pyramidal neurons (grey line).
A.R. Brown et al. / Neuropharmacology 103 (2016) 163e173 169neurosteroids, g-CD treatment signiﬁcantly reduced the decay time
of a1/ mIPSCs in P7 - 8, P10 and P15 a1/ neurons, but in
commonwith theirWTcounterparts, had no effect on the twof P20
- 24 a1/ mIPSCs (two-way ANOVA, age  treatment interaction,
F3, 58 ¼ 6.14, p ¼ 0.001; for post-hoc control vs g-CD comparisons,
p < 0.01 for a1/ P7 - 8, P10 and P15 neurons and p > 0.05 for P20-
24, Fig. 6). Similarly, ﬁnasteride (50 mM) treatment reduced the tW
of P7 - 8 a1/ mIPSCs, but had no such effect on P20 - 24 a1/
mIPSCs (two-way ANOVA, age  treatment interaction F2,43 ¼ 9.87,
p < 0.001; for post-hoc control vs ﬁnasteride comparisons, p < 0.05
for P7 e 8 and p > 0.05 for P20-24; Fig. 6, Table 2). These obser-
vations suggest that the duration of cortical mIPSCs is inﬂuenced
throughout the developmental period studied here by the expres-
sion of synaptic receptors incorporating the a1 subunit, but that
changes to the expression of a1-GABAARs are not exclusively
responsible for the altered mIPSC kinetics occurring within this
developmental window. Furthermore, in common with WT, the
waning of a neurosteroid tone is revealed to be an important
determinant of the duration of a1/ mIPSCs.
3.6. The role of neurosteroids in mediating the developmental
changes to phasic GABAergic transmission of L2/3 cortical
interneurons
We next investigated whether the developmentally regulatedTable 2
A summary of the impact of development and g-CD pre-incubation on the properties
Student's unpaired t-test.y ¼ p < 0.05,yy ¼ p < 0.01, vs control, one way ANOVA with Tuk
P7-8 P10
Control
(n ¼ 5)
g-CD
(n ¼ 8)
FIN
(n ¼ 5)
Control
(n ¼ 4)
g-C
(n ¼
Peak amplitude (pA) 57 ± 3 52 ± 2 60 ± 6 49 ± 2 51
Rise time (ms) 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.5
tW (ms) 18.7 ± 2.0 12.2 ± 1.0yy 12.9 ± 0.9y 16.0 ± 1.3 9.2
Frequency (Hz) ND ND ND 0.8 ± 0.3 1.5neurosteroid tone is speciﬁc for L2/3 pyramidal neurons, or is more
generally experienced by other neuronal populations. To identify
GABA-ergic interneurons we utilized GAD 67 GFP þ mice, engi-
neered to co-express green ﬂuorescent protein (GFP) with the
GABA-synthesising 67 kDa g-amino decarboxylase (GAD 67)
enzyme (Tamamaki et al. 2003). Co-localization studies revealed
that three major interneuron classes present in mouse neocortex,
(i.e. calretinin-, parvalbumin-, or somatostatin-expressing) are all
GFP-positive (Tamamaki et al. 2003). Using epiﬂuorescence mi-
croscopy, recordings from P7 - 8 GFP expressing neurons of L2/3,
revealed mIPSCs with a decay phase (tW ¼ 11.7 ± 0.8 ms, n ¼ 8;
Fig. 7 A, B, E - see Table 3 for additional properties), which at this
age is similar to that of pyramidal neurons (P7 - 8 L2/3 pyramidal
tW¼ 12.1 ± 0.3 ms, n¼ 55, p > 0.05, unpaired t-test), ofWTmice. In
common with cortical pyramidal neurons, the mIPSC properties of
GABA-ergic interneurons changed with development (Table 3). In
particular, P20 - 24 interneuron mIPSCs exhibited a much reduced
decay time (tW ¼ 4.5 ± 0.3 ms, n ¼ 14, p < 0.001, unpaired t-test,
Fig. 7 C, D, E, Table 3), compared to their younger counterparts.
For P7 - 8 GABA-ergic interneurons, intracellular g-CD (0.5 mM)
had no effect on either the mIPSC peak amplitude, rise time, or
frequency (in all cases p > 0.05 vs control, unpaired t-test), but
greatly reduced their decay time (P7 - 8 tW control ¼ 11.7 ± 0.8 ms,
n ¼ 8, tW ICS g-CD ¼ 7.6 ± 0.2 ms, n ¼ 8, p < 0.001, unpaired t-test,
Fig. 7 A, B, E, Table 3). However, the effect of intracellular g-CD was
signiﬁcantly inﬂuenced by developmental stage (two-way ANOVA,
age  treatment interaction, F1,33 ¼ 16.23, p < 0.001), such that the
mIPSC decay of P20 - 24 interneurons was no longer inﬂuenced by
the steroid scavenger (tW control ¼ 4.5 ± 0.3 ms, n ¼ 14; ICS g-CD
tW¼ 4.0 ± 0.4, n¼ 7, p > 0.05, unpaired t-test, Fig. 7 C, D, E, Table 3).
Therefore, phasic inhibition of L2/3 interneurons, in common with
pyramidal neurons, changes with development. Furthermore, early
in development a neurosteroid tone is experienced by the synaptic
GABAARs of both GABA-ergic interneurons and principal neurons,
which by P20 - 24 dissipates, resulting in brief phasic inhibitory
events.4. Discussion
4.1. Endogenous neurosteroids prolong the mIPSCs of cortical L2/3
neurons during development
Postnatal development is marked by periods of considerable
plasticity within cortical circuitry, wherein GABAergic neurotrans-
mission is driven towards rapid and effective phasic inhibition,
capable of supporting the complexity of mature cortical processing.
During this period, several mechanisms may contribute to the
mIPSC decay time, including: alterations in the subunit composi-
tion of synaptic GABAARs (Takahashi, 2005; Eyre et al. 2012), post-
translational modiﬁcations of synaptic proteins (Vithlani et al.
2011), the extent of receptor clustering (Petrini et al. 2003),
changes in the kinetics of GABA release and alterations to GABA
uptake (Mozrzymas, 2004). The latter is inﬂuenced by the activityof mIPSCs of a1¡/¡ L2/3 pyramidal neurons.**¼ p < 0.01,*** ¼ p < 0.001, vs control,
ey post hoc analysis.
P15 P20-24
D
4)
Control
(n ¼ 12)
g-CD
(n ¼ 9)
Control
(n ¼ 13)
g-CD
(n ¼ 11)
FIN
(n ¼ 7)
± 6 41 ± 3 39 ± 3 49 ± 3 47 ± 2 57 ± 3.8
± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.4 ± 0.1
± 1.1*** 13.5 ± 0.9 9.8 ± 0.4** 7.9 ± 0.4 7.9 ± 0.6 8.8 ± 0.4
± 0.3 3.9 ± 0.7 3.5 ± 1.0 12.5 ± 1.6 8.5 ± 1.2 ND
Fig. 6. A developmentally-regulated neurosteroid tone inﬂuences the decay time
of mIPSCs recorded from a1¡/¡ L2/3 neurons. A bar graph showing the effect of g-CD
pre-incubation (1 mM) on the tW of mIPSCs recorded from a1/ L2/3 pyramidal
neurons during development (n ¼ 4e13 cells). In common with WT L2/3 pyramidal
neurons, treatment of a1/ cortical brain slices with g-CD results in faster decaying
mIPSCs at P7 - 8, P10 and P15, but not at P20-24. For comparison, the effect of ﬁnas-
teride (50 mM) pre-incubation at P7 - 8 and P20 - 24 is also shown (n ¼ 7e14 cells).
yy ¼ p < 0.01, y ¼ p < 0.05 vs control, post hoc Tukey HSD test following a two-way
ANOVA. ** ¼ p < 0.01, *** ¼ p < 0.001, vs control, post-hoc independent samples t-
test following a two-way ANOVA. n.s. ¼ not signiﬁcant. The independent variables for
the two-way ANOVAs were postnatal age and treatment. Illustrated above each
developmental time point is the corresponding averaged and superimposed mIPSCs,
normalised with respect to peak amplitude, obtained from representative pyramidal
neurons of WT and a1/ in the absence (control, black line) and following 1 mM g-CD
pre-incubation (grey line).
Fig. 7. The effect of intracellular g-cyclodextrin (0.5 mM) on the decay kinetics of
mIPSCs recorded from P7 and P20 - 24 L2/3 cortical GAD67-GFP þ neurons. A, C).
Superimposed, averaged mIPSCs normalised with respect to peak amplitude from
representative P7 (A) and P20 (C) control L2/3 GFP þ neurons (black line) and L2/3
GFP þ neurons in which the intracellular solution contained 0.5 mM g-CD (grey line) at
P7 (A) and P20 (C). B, D). Cumulative probability plots of the mIPSC T50 for P7 (B) and
P20 - 24 neurons (D) control (black line) and ICS þ g-CD (grey line). In each case events
were pooled from n ¼ 8 GFP þ cells (P7 control), n ¼ 8 GFP þ cells (P7 ICSþ g-CD),
n ¼ 14 GFP þ cells (P20 - 24 control), and n ¼ 7 GFP þ cells (P20 - 24 ICSþ g-CD). For
P7, but not for P20 - 24 cells, the mIPSC T50 distribution is left-shifted indicating that
all mIPSCs recorded from P7 GFP þ cells treated with intracellular g-CD, exhibited
faster decay kinetics, compared with control (p < 0.001, KS-test). E). A summary bar
graph showing a signiﬁcant decrease in the mIPSC tW following intracellular g-CD
treatment at P7, but not at P20 - 24. n.s. ¼ not-signiﬁcant; *** ¼ p < 0.001 vs control,
post-hoc independent samples t-test following two-way ANOVA, with postnatal age
and treatment as the independent variables.
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the effects of transporter inhibitors on the time course of responses
to iontophoretically applied GABA, or on IPSCs evoked by repetitive
nerve stimulation are quite evident, they have relatively little effect
on the amplitude or kinetics of mIPSCs (Keros and Hablitz, 2005;
Scimemi, 2014). Our results indicate that in addition to a possible
involvement of such factors, during postnatal development the
mIPSCs of L2/3 pyramidal neurons become reduced in duration, at
least in part due to a programmed loss of the inﬂuence of endog-
enous neurosteroids upon synaptic GABAARs. The validity of our
conclusions is partly dependent on the speciﬁcity of g-CD in
sequestering neurosteroids. A previous study reported that b-CD
(0.5e1.5 mM), when applied to hippocampal neurons prolonged
the decay of macroscopic currents mediated by GABAARs (Pytel
et al. 2006). However, g-CD treatment of thalamic VB neurons,
cortical L2/3 interneurons and pyramidal cells induced a marked
reduction in the mIPSC decay time early in development, but had
no effect on this parameter at later developmental time-points (e.g.
P20-24; Brown et al., 2015). Furthermore, pre-incubationwith a-CD
had no effect on any of themIPSC properties at any age studied here
and most importantly the effects of g-CD on P7-8 neurons were
recapitulated by pre-incubation with the 5aR inhibitor ﬁnaste-
ride. A parsimonious explanation for the decreased duration of
immature L2/3 mIPSCs following g-CD treatment posits that the
steroid-sequestering molecule is effective in forming inclusion
complexes with endogenous neurosteroids, whereas the observed
insensitivity to a-CD reﬂects the hydrophobic inner cavity being too
small to accommodate steroids (Szejtli, 1998; Shu et al. 2004;
Brown et al. 2015).
Theoretically, the loss of neurosteroid inﬂuence on phasic in-
hibition with development may result from the synaptic GABAARs
becoming insensitive to this endogenous modulator (Koksma et al.
2003). However, acute application of 5a3a (1 mM) clearly prolonged
mIPSCs recorded from P20-24 cortical L2/3 pyramidal neurons.Furthermore by pre-incubating the tissue with a lower, aqueous
concentration (100 nM) of 5a3a, we demonstrated these synaptic
GABAARs to be highly sensitive to the neurosteroid at this stage of
development. Alternatively, a change in steroid enzyme expression,
or a lack of steroid substrate(s) may be implicated in this devel-
opmental plasticity. We previously demonstrated that incubation
of mouse thalamic slices with 5a-DHP, the immediate precursor of
5a3a, greatly increased the duration of the mIPSCs of VB neurons
(Brown et al. 2015). Similarly here, incubation of P20 - 24 cortical
tissue with 5a-DHP greatly prolonged the mIPSCs of cortical pyra-
midal neurons and in common with thalamic neurons, this effect
was prevented by co-incubation with the 3a-HSD inhibitor indo-
methacin, or reversed by intracellular g-CD (Brown et al. 2015).
Collectively these results suggest that the developmental change to
phasic inhibition of cortical pyramidal neurons occurring between
P7 and P20 results in a part from a lack of steroid substrate.
4.2. Location of neurosteroid synthesis and action
Previous histochemical studies support the concept of a local
Table 3
A summary of the effects of intracellular g-CD treatment on the properties of mIPSCs of L2/3 GAD 67 GFP þ neurons.*** ¼ p < 0.001, vs control, unpaired t-test.
P7 control
(n ¼ 8)
P7 g-CD
(n ¼ 8)
P20-24 control
(n ¼ 14)
P20-24 g-CD
(n ¼ 7)
Peak amplitude (pA) 74 ± 7 61 ± 5 62 ± 4 59 ± 7
Rise time (ms) 0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.1
tW (ms) 11.7 ± 0.8 7.6 ± 0.2*** 4.5 ± 0.3 4.0 ± 0.4
Frequency (Hz) 0.3 ± 0.1 0.2 ± 0.1 2.7 ± 0.5 2.1 ± 0.9
A.R. Brown et al. / Neuropharmacology 103 (2016) 163e173 171neurosteroid synthesis in cortex. In mouse cortex the staining for
mRNA encoding for the 5a3a synthesising enzymes 5a-reductase
Type I (5a-R I) and 3a-hydroxysteroid dehydrogenase (3a-HSD),
was co-located in layer 2/3/5 pyramidal neurons (Agis-Balboa et al.
2006). The 5a-R I staining co-localised with that for the vesicular
glutamate transporter (VGLUT1), a marker of glutamatergic neu-
rons (Agis-Balboa et al. 2006). By contrast, the 5a-R I, or the 3a-HSD
staining did not co-localize with a marker for GABA-ergic neurons,
or for glia (Agis-Balboa et al. 2006). In apparent agreement, an
antibody raised against 5a3a revealed staining for this GABAAR-
active steroid in rat cortical L2-6 pyramidal neurons, but not in cells
that had the appearance of GABA-ergic interneurons, or glia, but
note were not categorically identiﬁed by speciﬁc neurochemical
markers of interneuron subtypes (Saalmann et al. 2007). However,
a recent study identiﬁed expression of 5aR Type II in cortical
GABAergic cells, suggesting that neurosteroid synthesis and action
may not always be conﬁned to principal excitatory neurons (Castelli
et al. 2013).
Whether cortical principal cells or interneuron populations are
the locus of neurosteroid synthesis is not directly addressed by our
ﬁnasteride, or intracellular g-CD experiments. If at P7 - 8 the mode
of neurosteroid action is exclusively autocrine, then a ubiquitous
expression of steroid-synthesizing enzymes across different
neuronal populations would be required. Alternatively, the local
steroid concentration present during neonatal development may
be sufﬁcient to impact upon GABA-ergic and/or principal neurons,
which are incapable of neurosteroid synthesis, thereby inferring a
paracrine mode of action. Clearly, further studies are required to
clarify the relative contribution of autocrine and paracrine neuro-
steroids to the inhibitory plasticity of the developing cortex.
Irrespective of the locus of synthesis, the lipophilic steroid is
considered to access the synaptic GABAARs by lateral diffusion via
the plasma membrane, a mechanism congruent with the proposed
transmembrane neurosteroid binding site on the receptor (Hosie
et al. 2006; Chisari et al. 2010). Numerous in vitro electrophysio-
logical studies report enhancement of GABAAR function by low nM
aqueous concentrations of 5a3a (see Belelli and Lambert, 2005),
advocating the presence of a relatively high afﬁnity binding site on
the GABAAR. However, such neurosteroids are highly lipophilic,
permitting much greater local concentrations to accumulate in the
vicinity of the receptor, obviating the requirement for a high afﬁnity
binding site. Indeed, the proposed low afﬁnity binding site (Chisari
et al. 2010) is consistent with our observation that evenwhen g-CD
was applied exclusively to the cytosolic compartment, it efﬁciently
removed the neurosteroid inﬂuence on synaptic GABAARs of
immature cortical pyramidal neurons.
4.3. The role of GABAAR subunit composition in developmental
plasticity of phasic GABAergic neurotransmission
The a1 subunit mRNA and protein is present in the cortex early
in development, albeit at low levels, whereas the converse is true
for a2/3 subunits, which are highly expressed early in life, before
they decrease to lower levels in the mature cortex (Laurie et al.
1992; Fritschy et al. 1994; Pirker et al. 2000). Here the mIPSCsobtained from a1/ L2/3 pyramidal neurons at P7 - 8, P10, P15 and
P20 - 24 exhibited slower decay kinetics c.f. WT controls at each
developmental time-point. Since a1-GABAARs are associated with
fast decay kinetics (Picton and Fisher, 2007), this ﬁnding suggests
that a proportion of synaptic a1-GABAARs are present even at P7 - 8
in L2/3 pyramidal neurons. However, a developmental decrease of
the mIPSC decay time of a1/ L2/3 pyramidal neurons was still
evident, implying the presence of additional factors, as previously
suggested (Bosman et al. 2005). Moreover, the developmental
proﬁle of g-CD sensitivity for mIPSCs from P7 - 8, P10 and P15 a1/
L2/3 pyramidal neurons was indistinguishable to WT. In summary,
these ﬁndings indicate that although the duration of the mIPSCs is
inﬂuenced by the a1 subunit, it is not solely responsible for the
developmental changes that occur in the postnatal period P7 e 20.
The results presented here reveal the waning impact during
development of the endogenous neurosteroid tone is an additional
important factor in inﬂuencing phasic GABAergic neurotransmis-
sion of both WT and a1/ L2/3 pyramidal neurons. However, a
comparison of the mIPSC decay of P7 - 8 and P20 - 24 a1/ neu-
rons, when treated with either ﬁnasteride, or g-CD, reveals an
additional, as yet unidentiﬁed factor(s) that inﬂuences phasic
GABAergic neurotransmission during postnatal development.
4.4. The physiological role of GABAAR-active neurosteroids during
development
This study focused on L2/3 cortical neurons and found that the
synaptic GABAARs expressed on both pyramidal and interneuron
populations are developmentally inﬂuenced by neurosteroids to
modulate the duration of GABAergic synaptic transmission. These
changes in neurosteroid inﬂuence are occurring during an intense
period of synaptogenesis, which may be reﬂected by our observa-
tion that the frequency of mIPSCs increases during postnatal
development. Furthermore, at this time GABA may exert a depo-
larizing effect due to the dominance of the chloride importer
NKCC1 (Owens et al. 1996; Ben-Ari et al. 2007). Hence, long dura-
tion synaptic events may be suited to recruiting voltage-gated
calcium channel activation, which in turn may initiate various
Ca2þ-dependent processes in the neuron. In this scenario, the
emergence of mature (hyperpolarizing) GABA-ergic signalling
would inversely correlate with the decline of neurosteroid pro-
duction. Adding complexity, a recent report has demonstrated that
neonatal administration of 5a3a inﬂuences the hippocampal
expression of the Kþ Cl co-transporter KCC2 (Modol et al., 2014).
We recently reported a similar developmentally controlled
neurosteroid tone in somatosensory thalamocortical neurons
(Brown et al. 2015). During development, the window of neuro-
steroid inﬂuence on GABA-ergic transmission in the somatosensory
thalamus is shorter than that described here for cortex. In thalamic
neurons the neurosteroid tone was absent by P10 (Brown et al.
2015), whereas in cortex this form of endogenous modulation
persisted through to P15, but was no longer present by P20 - 24. The
reasons for the distinct temporal regulation between thalamus and
cortex are unknown. In addition to thalamus and cortex, previous
studies have identiﬁed a similar neurosteroid tone in spinal
A.R. Brown et al. / Neuropharmacology 103 (2016) 163e173172neurons of the dorsal horn (Keller et al. 2004), which also exhibits a
differential developmental proﬁle for lamina II and lamina III/IV
neurons (Inquimbert et al. 2008). Hence, the existence of a neu-
rosteroid tone at multiple tiers of the CNS suggests a widespread
role during postnatal development. Deciphering the interplay be-
tween endogenous neurosteroid synthesis, GABAAR potentiation,
and neuronal maturation should therefore be a focus for future
studies.
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